2025 annual financial data
Humacyte 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -5,154.17%.
Operating income was -107,437,000 USD and net income was -40,833,000 USD.
Operating cash flow was -105,042,000 USD.
Get free Humacyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,038,000 USD
- Operating income
- -107,437,000 USD
- Net income
- -40,833,000 USD
- Operating cash flow
- -105,042,000 USD